ASH 2023 | Gene expression profiles in subtype characterization and disease evolution of WM
Zachary Hunter
• 10 Dec 2023
Zachary Hunter, PhD, Dana-Farber Cancer Institute, Boston, MA, discusses a multi-omic study investigating genomic and transcriptomic alterations that underlie subtype classification and disease evolution in Waldenström’s macroglobulinemia (WM). Dr Hunter highlights the highly disorganized gene expression pattern on CD19-expressing Waldenström’s B-cells, which manifests in early disease stages. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
